Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_636_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Puborectalis Muscle
- •Iliococcygeus Muscle
- •Pubococcygeus Muscle
- •Mesorectum
- •Presacral Fascia
- •Retrosacral Fascia
- •Waldeyer’s Fascia
- •Denonvilliers’ Fascia
- •Lateral Ligaments
- •Anorectal Spaces
- •Perianal Space
- •Intersphincteric Space
- •Submucous Space
- •Ischioanal/Ischiorectal Space
- •Supralevator Space
- •Anal Canal Epithelium
- •Internal Anal Sphincter
- •Conjoined Longitudinal Muscle
- •External Anal Sphincter
- •Perineal Body
- •Pelvic Floor Muscles
- •Retrorectal Space
- •Rectal Blood Supply
- •Superior Rectal Artery
- •Middle Rectal Artery
- •Inferior Rectal Artery
- •Cecum
- •The Appendix
- •Ascending Colon
- •Transverse Colon
- •Descending Colon
- •Sigmoid Colon
- •Rectosigmoid Junction
- •Blood Supply
- •Superior Mesenteric Artery
- •Inferior Mesenteric Artery
- •Venous Drainage
- •Lymphatic Drainage
- •Nervous Innervation
- •Embryology
- •Non-rotation
- •Malrotation
- •Reversed Rotation
- •Omphalocele
- •Internal Hernias
- •Proximal Colon Duplication
- •Meckel’s Diverticulum
- •Hirschsprung’s Disease
- •Anorectal Malformations
- •Anal Stenosis
- •Membranous Atresia
- •Anal Agenesis
- •Anorectal Agenesis
- •Rectal Atresia or “High Atresia”
- •Persistent Cloaca
- •2: Colonic Physiology
- •Colonic Anatomy
- •Introduction
- •Colonic Wall Anatomy
- •Colonic Epithelial Cell Types
- •Colonic Flora
- •Electrolyte Regulation and Water Absorption
- •Short-Chain Fatty Acid Absorption
- •Secretory Role of the Colonic Epithelium
- •Regulation of Electrolyte and Water Absorption and Secretion
- •Colonic Innervation
- •Colonic Motility
- •Cellular Basis of Motility
- •Motility Patterns and Measurement
- •Introduction
- •Normal Continence
- •Rectal Capacity
- •Structural Considerations
- •Normal Defecation
- •Obstructed Defecation
- •Functional Anorectal Pain
- •4: Endoscopy
- •Introduction
- •The Complete Anorectal Examination
- •Patient Position
- •Prone Jackknife
- •Left Lateral
- •Digital Rectal Examination
- •Anoscopy/Proctoscopy
- •Anoscopy
- •Proctoscopy
- •Flexible Endoscopy
- •Flexible Endoscopic Insertion Techniques
- •Torque
- •Dithering/Jiggle
- •Slide-By
- •Special Considerations
- •The Patient Requiring Antibiotics
- •The Anticoagulated Patient
- •Incomplete Colonoscopy
- •Procedure
- •The Endoscopy Suite
- •Instruments
- •Sedation
- •Nitrous Oxide
- •Ketamine
- •Propofol
- •Colonoscopy Technique
- •Anal Intubation
- •Sigmoid Colon
- •Sigmoid-Descending Junction
- •Descending Colon
- •Splenic Flexure
- •Transverse Colon
- •Hepatic Flexure
- •Cecum
- •Patient Position
- •Abdominal Pressure
- •Sigmoidoscopy
- •Colonoscopy
- •Bowel Preparation
- •Ileocecal Valve Intubation
- •Terminal Ileum
- •Alternate Techniques
- •Chromocolonoscopy (Chromoendoscopy)
- •Full-Spectrum Endoscopy
- •Complications
- •Sedation Complications
- •Vasovagal/Cardiac Arrhythmia
- •Pulmonary
- •Procedural Complications
- •Splenic Injury
- •Perforation
- •Post-polypectomy Syndrome
- •Bleeding
- •Infectious Complications
- •Simulation
- •Documentation
- •Quality
- •PillCam Endoscopy
- •Introduction
- •Polypectomy Techniques
- •Endoscopic Mucosal Resection
- •Endoscopic Submucosal Dissection
- •Combined Endo-Laparoscopic Surgery (CELS)
- •Major Abdominal Surgery
- •Anorectal Surgery
- •Preoperative Testing
- •Laboratory Studies
- •Electrocardiogram
- •Chest X-ray
- •Initial Workup
- •Who Needs Additional Testing?
- •Preoperative “Optimization”
- •Coronary Stent Management
- •AICD/Pacemaker Management
- •COPD
- •Obstructive Sleep Apnea (OSA)
- •Diabetes
- •Obesity
- •Malnutrition
- •Solid Organ Transplant Recipients
- •Substance Abuse
- •Alcohol
- •Tobacco
- •Opioids
- •Medications
- •Anticoagulation
- •Immunosuppressive Agents
- •Chemotherapy
- •Introduction
- •Preoperative Management
- •Patient Education
- •Intraoperative Pathway
- •Minimally Invasive Colorectal Surgery
- •Intraoperative Fluid Administration
- •Analgesia
- •Venous Thromboembolism (VTE) Prophylaxis
- •Postoperative Recovery
- •Analgesia
- •Intravenous Fluid Management
- •Venous Thromboembolism (VTE) Prophylaxis
- •Quality Pathway Evaluation Measures
- •Quality Improvement Measures
- •8: Postoperative Complications
- •Introduction
- •Ureteral Injury
- •Bladder Injury
- •Urethral Injury
- •IV Fluid Management
- •Wound Management
- •Bladder Management
- •Pain Management
- •Academic Medical Center
- •Wound Complications
- •Preoperative Considerations
- •Perioperative Interventions
- •Long-Term Complications
- •Genitourinary Complications
- •Fertility Complications
- •Bowel Dysfunction
- •9: Anastomotic Construction
- •Introduction
- •Surgical Staplers
- •Handsewn Anastomoses
- •Compression Anastomoses
- •Tension
- •Blood Supply
- •Prophylactic Drainage
- •Diversion
- •High-Risk Anastomoses
- •Abdominal Anastomoses
- •Small Bowel Anastomoses
- •Ileocolic Anastomoses
- •Pelvic Anastomoses
- •Stapled Colorectal Anastomoses
- •Handsewn Colorectal Anastomosis
- •Ileorectal Anastomosis
- •Neorectal Reservoirs
- •Handsewn Coloanal Anastomosis
- •Unanticipated Pelvic Anastomosis
- •Inadequate Colonic Length
- •Intraoperative Anastomotic Failure
- •10: Anastomotic Complications
- •Anastomotic Leak
- •Overview
- •Consequences
- •Prevention
- •Diagnosis
- •Treatment
- •Anastomotic Stricture
- •Anastomotic Bleeding
- •Introduction
- •Patient History
- •Levator Syndrome
- •Physical Examination
- •Abdominal Examination
- •Inguinal Examination
- •Digital Rectal Examination
- •Conclusion
- •12: Hemorrhoids
- •Anatomy
- •Etiology
- •Epidemiology
- •Clinical Presentation
- •History
- •Physical Examination
- •Treatment
- •Medical Management
- •Dietary
- •Topical Therapies
- •Oral Therapy
- •Rubber Band Ligation
- •Infrared Photocoagulation
- •Sclerotherapy
- •Excisional Hemorrhoidectomy-Closed Technique
- •Excisional Hemorrhoidectomy Open Technique (Milligan-Morgan)
- •Excisional Hemorrhoidectomy (Circumferential or Whitehead)
- •Urinary Retention
- •Postoperative Hemorrhage
- •Anal Stenosis
- •Postoperative Infection
- •Fecal Incontinence
- •Stapled Hemorrhoidopexy
- •Transanal Hemorrhoidal Dearterialization
- •Special Clinical Scenarios
- •Thrombosed External Hemorrhoid
- •Pregnancy
- •Crohn’s Disease
- •Immunocompromised Patients
- •13: Anal Fissure
- •Pathogenesis
- •Non-operative Treatment
- •Healing Rates in Acute Anal Fissure
- •Healing Rates in Chronic Anal Fissure
- •Topical
- •Nitroglycerin
- •Calcium Channel Blockers
- •Botulinum Toxin Type A
- •Operative Treatment
- •Anal Dilation
- •Anal Sphincterotomy (Technique)
- •Outcomes Between Closed and Open Anal Sphincterotomy
- •Extent of Sphincterotomy
- •Fissurectomy
- •Results of Sphincterotomy
- •Fissures Without Anal Hypertonicity
- •Crohn’s Disease
- •Conclusions
- •Pathophysiology
- •Anatomy
- •Etiology
- •Evaluation
- •Physical Examination
- •Imaging
- •Computed Tomography (CT)
- •Magnetic Resonance Imaging (MRI)
- •Endoanal Ultrasound (EAUS)
- •Transperineal Sonography (TP-US)
- •Treatment
- •Catheter Drainage
- •Postoperative Management
- •Complications
- •Immediate Postoperative Period
- •Misdiagnosis
- •Special Considerations
- •Necrotizing Anorectal Infection (Fournier’s Gangrene)
- •Diagnosis
- •Treatment
- •Outcomes
- •Anal Fistula
- •Etiology
- •Diagnosis
- •Fistulography
- •Endoanal Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Lay-Open Technique (Fistulotomy)
- •Setons
- •Advancement Flap
- •Technique
- •Technique
- •Fibrin Glue
- •Technique
- •Anal Fistula Plug
- •Technique
- •Novel Techniques
- •15: Complex Anorectal Fistulas
- •Introduction
- •Complex or Recurrent Cryptoglandular Fistulas
- •Surgical Treatment
- •Seton
- •Anal Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Outcomes
- •Seton
- •Advancement Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Rectourethral Fistulas
- •Surgical Treatment
- •Transanal Approach
- •Posterior Approach
- •Transperineal Approach
- •Transabdominal Approach
- •Outcome
- •Postoperative Fistulas
- •Surgical Treatment
- •Outcome
- •16: Rectovaginal Fistula
- •Obstetric Injury
- •Cryptoglandular Disease
- •Crohn’s Disease
- •Endorectal Repairs
- •Transperineal Repairs
- •Tissue Transposition Repairs
- •Martius Flap
- •Gracilis Muscle Transposition
- •Transvaginal Repairs
- •Transabdominal Repair
- •Alternate Repairs
- •Background
- •Etiology
- •Clinical Presentation/Diagnosis
- •Treatment
- •Non-operative Management
- •Operative/Excisional Management
- •Basic Procedures
- •Complex Procedures
- •Karydakis Flap
- •Cleft Lift Procedure (See Video 17.1)
- •Rhomboid/Limberg Flap (See Video 17.2)
- •Disease Recurrence
- •Hidradenitis Suppurativa
- •Etiology/Presentation/Diagnosis
- •Treatment
- •Medical Therapy
- •Surgical/Excisional Therapy
- •Introduction
- •Irritants
- •Steroid-Inducing Itching
- •Infectious
- •Dermatologic
- •Neoplasms
- •Anorectal Conditions
- •Systemic Diseases
- •Physical Examination
- •Infectious
- •Dermatologic
- •Neoplasms
- •Biochemical Testing
- •Microbiology Testing
- •Patch Testing
- •Anoscopy: Proctoscopy
- •Biopsy
- •Evidence-Based Management
- •Primary Prutitis Ani
- •Secondary Prutitis Ani
- •Infectious
- •Dermatologic
- •Systemic Diseases
- •19: Sexually Transmitted Infections
- •Introduction
- •Perianal or Genital Lesions
- •Proctitis
- •Proctocolitis
- •Enteritis
- •Gonorrhea
- •Epidemiology
- •Clinical Presentation
- •Emerging Antibiotic Resistance
- •Chlamydia
- •Epidemiology
- •Clinical Presentation
- •Lymphogranuloma Venereum
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Syphilis
- •Epidemiology
- •Clinical Presentation
- •Testing Recommendations
- •Treatment
- •Chancroid
- •Granuloma Inguinale aka Donovanosis
- •Herpes
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Human Papillomavirus
- •Epidemiology
- •Clinical Presentation
- •Testing
- •Treatment
- •Vaccine
- •Epidemiology
- •Testing
- •Anorectal Issues
- •Molluscum Contagiosum
- •Pubic Lice: Phthirus pubis
- •Scabies
- •20: Anal Intraepithelial Neoplasia
- •Introduction
- •Symptoms
- •Epidemiology
- •Screening/Surveillance
- •Diagnosis
- •Treatment
- •Management Strategies
- •Progression
- •Prevention
- •21: Anal Cancer
- •Anal Squamous Cell Carcinoma
- •Anal Melanoma
- •Anal Adenocarcinoma
- •22: Presacral Tumors
- •General Considerations
- •Anatomic Considerations
- •Diagnosis
- •Management
- •Outcomes
- •Chromosomal Instability
- •Microsatellite Instability
- •CpG Island Methylator Phenotype (CIMP)
- •Adenomatous Polyposis Syndromes
- •Familial Adenomatous Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •FAP Extracolonic Manifestations
- •Management
- •Screening
- •Treatment
- •Colorectal
- •Duodenal Adenomas
- •Desmoid Disease
- •Thyroid Neoplasia
- •MUTYH-Associated Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Extracolonic Cancer Risk
- •Management
- •Screening
- •Treatment
- •Polymerase Proofreading-Associated Polyposis
- •Hamartomatous Polyposis Syndromes
- •Juvenile Polyposis Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Screening
- •Treatment
- •Peutz-Jeghers Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Surveillance
- •Polypectomy
- •Surgery
- •PTEN Hamartoma Tumor Syndrome (PHTS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk Management
- •Serrated Polyposis Syndrome (SPS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Management
- •Screening
- •Treatment
- •Lynch Syndrome
- •Genotype-Phenotype Correlations
- •Muir-Torre Syndrome (MTS)
- •Turcot’s Syndrome
- •Colorectal Cancer Risk
- •Other LS-Associated Cancer Risk
- •Diagnosis
- •Individual Whose Family Meets Amsterdam Criteria but Does Not Have Any Clinical Phenotype
- •Clinical Management
- •Screening
- •Introduction
- •Recommended Screening Guidelines
- •Screening Cessation
- •Colonoscopy
- •Incomplete Colonoscopy
- •Complications
- •CT Colonography (CTC) or Virtual Colonoscopy
- •Flexible Sigmoidoscopy
- •Complications
- •Fecal Occult Blood Testing (FOBT)/Fecal Immunochemical Testing (FIT)
- •Stool DNA Testing
- •Double-Contrast Barium Enema (DCBE)
- •Surveillance
- •History
- •Adenoma
- •Hamartomas Polyps
- •Early Cancer (T1) Within Polyp
- •Chemoprevention
- •Background
- •Clinical Presentation
- •Preoperative Evaluation
- •Tumor Localization
- •Total Colon Evaluation
- •Carcinoembryonic Antigen (CEA)
- •Radiographic Evaluation
- •Lymph Node Evaluation
- •Lynch Syndrome Phenotype
- •26: The Surgical Management of Colon Cancer
- •Preoperative Preparation
- •Physiologic Assessment
- •Tumor Localization
- •Surgical Technique
- •Extent of Resection
- •Mesocolic Resection
- •Right Colectomy
- •Open Approach
- •Lateral-to-Medial Approach
- •Posterior (Inferior-to-Superior) Approach
- •Superior to Inferior Approach
- •Medial-to-Lateral Approach
- •Anastomosis
- •Laparoscopic Approach
- •Medial-to-Lateral Approach
- •Posterior (Inferior-to-Superior) Approach
- •Left Colectomy
- •Open
- •Anastomotic Assessment
- •Hand-Assisted Medial-to-Lateral Approach
- •Subtotal Colectomy
- •Open Approach
- •Laparoscopic Approach
- •Total Abdominal Colectomy with Ileorectal Anastomosis
- •Special Circumstances
- •Laparoscopy
- •Obstructing Colon Cancers
- •Perforated Colon Cancers
- •Management of Primary Colon Cancer in the Setting of Distant Metastasis
- •Outcomes for Colon Cancer
- •Short-Term Outcomes
- •Long-Term Outcomes
- •Introduction
- •Total Colon Evaluation
- •Locoregional Imaging
- •Computed Tomography
- •Endorectal Ultrasound
- •T Staging
- •N Staging
- •Magnetic Resonance
- •Whole-Body Imaging
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •28: Rectal Cancer: Neoadjuvant Therapy
- •Introduction
- •Historical Context
- •Postoperative Radiotherapy
- •Preoperative Radiotherapy
- •Radiosensitizing Agents
- •Preoperative Versus Postoperative Radiation
- •Short- Versus Long-Course Preoperative Radiotherapy
- •Choosing Optimal Treatment Regimens
- •The European Approach
- •Selected Adjuvant Systemic Chemotherapy
- •Selective Nonoperative Management
- •Techniques
- •Results
- •Lymphovascular Invasion
- •Tumor Budding
- •Introduction
- •Neoadjuvant Chemoradiotherapy
- •31: Proctectomy
- •Pathological Assessment
- •Preoperative Preparation
- •Operative Approaches
- •Open Low Anterior Resection (LAR)
- •Laparoscopic Low Anterior Resection
- •Robotic Low Anterior Resection
- •Abdominoperineal Resection (APR)
- •Extralevator or “Cylindrical” APR
- •Special Considerations
- •Distal Margin
- •Coloanal Anastomosis
- •Fecal Diversion
- •Extended Resection
- •Intraoperative Radiation Therapy
- •Flap Closure Following Abdominoperineal Resection
- •Functional Outcomes
- •Oncologic Outcomes
- •Multidisciplinary Rectal Cancer Care
- •32: Rectal Cancer Decision-Making
- •Assessment
- •Early Rectal Neoplasms
- •Local Excision
- •Endoscopically Excised Malignant Polyps
- •Surgical Considerations
- •Intraoperative Decisions
- •Midrectal Cancers
- •Low Rectal Cancers
- •Low Hartmann Resection Versus APR
- •Special Situations
- •Obstructing Rectal Cancer
- •Perforated Rectal Cancer
- •Synchronous Hepatic Metastases
- •33: Colorectal Cancer: Postoperative Adjuvant Therapy
- •Colon Cancer
- •Stage III Colon Cancer
- •Stage II Colon Cancer
- •Rectal Cancer
- •Patients Who Did Not Undergo Neoadjuvant Therapy
- •Patients Who Underwent Neoadjuvant Radiotherapy/Chemoradiotherapy
- •Patients Undergoing Local Excision
- •34: Colorectal Cancer: Surveillance After Curative-Intent Therapy
- •Introduction
- •Physical Examination
- •Laboratory Testing
- •Abdominal Imaging
- •Chest Imaging
- •Colonoscopy
- •Stage 1 Disease
- •Cost
- •Introduction
- •Determining Resectability
- •Multimodal Therapy Including Intraoperative Radiation
- •General Considerations
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Recurrences that Extend Anteriorly
- •Resection that Includes Sacrectomy
- •Stage I: Anterior Component
- •Stage II: Posterior Component
- •Stage III: Spinal Reconstructive Component
- •Soft Tissue Reconstruction
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Sacropelvic Resections
- •Palliative Approach
- •Introduction
- •Diagnostic Strategies
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •Magnetic Resonance Imaging
- •Contrast-Enhanced Ultrasound
- •Biopsy
- •Multidisciplinary Evaluation
- •Surgical Emergency
- •Self-Expanding Intraluminal Metal Stents
- •Liver-First Strategy
- •Colon-First Strategy
- •Margin Status
- •Other Liver Metastasis Strategies: Hepatic Intra-arterial Chemotherapy/Chemoembolization
- •Pulmonary Metastasis
- •Peritoneal Metastasis
- •Ovarian Metastases
- •Bone
- •Brain
- •Pancreas
- •Adrenal
- •Retroperitoneal Lymph Nodes
- •37: Appendiceal Neoplasms
- •Introduction
- •Epidemiology
- •Epithelial Neoplasms
- •Neuroendocrine Appendiceal Lesions/Carcinoid Tumors
- •Goblet Cell Carcinoids
- •Clinical Features
- •Diagnostic Procedures
- •Medical Management
- •Appendectomy
- •Right Hemicolectomy

192
B. R. Davis and K. R. Kasten
suspect that the external sphincter muscle will
be involved.
• Goodsall’s rule can be applied to help locate
the internal opening.
– The transverse anal line is of importance as
external openings.
– Fistulas that are located anteriorly are pos-
tulated to drain to an internal opening radially situated.
– Posterior external openings drain to the
posterior midline.
– The positive predictive value of Goodsall’s
rule (Fig.14.14) has been estimated to be
59% and is more accurate for posteriorly
located stulas.
• Palpation of the anal canal using the pad of an
experienced nger can frequently determine
the location of the internal opening by subtle
changes in the anoderm.
• Anoscopy is helpful to exclude inammatory
conditions of the anal canal or other potential
causes of the stula, but the internal opening
is rarely seen unless pus is draining from it.
• Preoperative imaging (CT or MRI) is reserved
for:
– Patients with multiple external openings
– Those in which an internal opening cannot
be identied on physical exam either preoperatively or intraoperative
– In cases of recurrence following surgical
procedures
Fistulography
• Water-soluble contrast injected into the external opening under uoroscopy using a small
feeding tube (Fig.14.15).
• Due to the limitation of plain lm imaging,
more recent attempts at stulography have
incorporated CT imaging in combination with
contrast injection.
• Limited value given the alternatives available in
modern radiology suites or colorectal ofces.
Fig. 14.13 External opening noted left anterolateral with
heaped-up edge
3cm
e
x
c
e
p
t
i
o
n
Curved tracts
transverse line
Straight tracts
Fig. 14.14 Goodsall’s rule for anal stula
Endoanal Ultrasound
• Characterize complex stula and their relationship to the sphincter complex.
• Fistulas appear as a hypoechoic track, which
can be enhanced by the instillation of hydro-
Fig. 14.15 Fistulography of complex anal stula (arrow
on stula tract)

14 Anorectal Abscess andFistula
193
gen peroxide or a LevovistTM into the external
opening.
• Can also help determine the presence of secondary tracts as well as horseshoe extensions.
• Conicting data regarding any advantage
compared to intraoperative assessment/
ndings.
• The results of these studies are inuenced by
the expertise and experience of the endosonographer and results may not be reproducible in all surgeons’ hands.
Magnetic Resonance Imaging
• The introduction of the 1.5 Tesla (T) and 3.0 T
magnets in the acquisition of images has
negated the need for the endoanal coil in the
evaluation of anal and rectal disease.
• Magnetic resonance imaging (MRI) of the
sphincter complex has some advantages in
diagnosing anal stulas.
– No instrumentation of the anus is required,
and the exam is not operator dependent.
– Able to demonstrate hidden areas of sepsis
and secondary extensions, both of which
contribute to the high rate of recurrence
after surgery.
– MR imaging can be used to dene the ana-
tomic relationships of the stula to predict
the likelihood of postoperative fecal
incontinence.
• Taken together, multiple studies conrm that
MR imaging is an accurate modality for evaluation of perianal stulas and associated complications. T.
• The most cost-effective algorithm for managing all patients with anal stula has yet to be
established.
• Preoperative imaging should be considered
when recurrent stula are encountered following treatment, in cases in which multiple
external openings exist and when the anatomy
is unclear either in the ofce or at the time of
surgery.
3. Preservation of patient’s fecal continence
and sphincter function
4. Minimizing recurrence
• Identication of the external and internal
opening is critical.
– Physical examination in the operating room
is quite reliable.
– Inject either methylene blue or hydrogen
peroxide into the external opening (83%
success) 83% of cases.
– A gently curved probe inserted into the
external opening is an alternative technique for nding the internal opening
(Fig.14.16).
– Care must be taken not to create a false
passage.
◦ Chronic tracks will have granulation tis-
sue within them and its absence should
raise the suspicion that a false track was
created following a stulotomy.
– The ultimate choice of treatment will
depend on the amount of sphincter involved
in the stula track.
◦ Cutting procedures more likely for inter-
sphincteric and low transsphincteric
stula
◦ Non-cutting techniques for all others
Lay-Open Technique (Fistulotomy)
• For simple and most distal or intersphincteric
stula (Table14.3).
Treatment
• The goals however of surgical treatment:
1. Elimination of sepsis
2. Closure of the stula track
Fig. 14.16 Probe through the external and internal opening of the anal stula

194
Table 14.3 Experience with stulotomy in treating anal stula
Author Year Surgical procedure # patients Outcome Follow-up
Kronborg 1985 Fistulotomy 26 Recurrence 11% 12months
Hebjorn 1987 Incision and drainage with
Schouten 1991 Incision and drainage with
Tang 1996 Incision and drainage with
Ho Y 1997 Incision and drainage with
Ho 1998 Fistulotomy 52 Healing time 10weeks
Belmonte
Montes
Oliver 2003 Incision and drainage with
Pescatori 2006 Fistulotomy 52 Minor incontinence 8.3%
Atkin 2011 Fistulotomy 180
Tozer 2013 Fistulotomy 50 Recurrence 7%
Hall 2014 Fistulotomy 146 Recurrence 6% 3months
1999 Fistulotomy 24 Incontinence 5% 12months
stula surgery
stula surgery
stula surgery
stula surgery
stula surgery
20 Recurrence 10%
Minor incontinence 8.3%
36 Recurrence 3%
Minor incontinence 39%
24 Recurrence 0%
Minor incontinence 0%
24 Recurrence 0%
Minor incontinence 0%
Minor incontinence 11%
100 Recurrence 5%
Minor incontinence 6%
Recurrence 8.3%
Minor incontinence 20%
B. R. Davis and K. R. Kasten
12months
42.5months
12months
15.5months
9weeks
12months
10months
11months
• Fistulotomy wounds typically heal after
4–6weeks, which may be shortened by marsupializing the wound edges.
• Recurrence and incontinence are the most signicant complication and rates vary widely.
– 4% of patients with intersphincteric stula
– 7% with transsphincteric stula
– 33% for suprasphincteric and extrasphinc-
teric stulas
• Incontinence increased with the complexity of
the stula (up to 34%).
• Lowest for intersphincteric stula (37%) and
highest for extrasphincteric stula (83%).
• Factors associated with recurrence included
type and extension of the stula, lack of identication or lateral location of the internal
opening, previous stula surgery, and the surgeon experience.
• Incontinence was associated to female sex,
high anal stula, type of surgery, and previous
stula surgery.
• Most complex anal stulas and stulas associated with Crohn’s disease are specic examples in which a lay-open technique would
have signicant or complete impairment of
fecal continence or when healing of the subsequent wound would not be expected to occur
(Fig.14.17).
Fig. 14.17 Seton in anal stula
Setons
• A variety of materials have been described for
use as setons including wire, non-absorbable
suture such as silk, vessel loops, and silastic
catheters.
• Placed loosely in an effort to promote drainage and brosis of the stula track either as a
bridge to a non-cutting repair or as denitive
treatment.
• Alternatively they may be tightened sequentially over time as a cutting seton in an effort
to slowly divide the sphincter muscle over
days to weeks and preserve continence by

14 Anorectal Abscess andFistula
195
allowing a scar to form between the cut ends
of the sphincter complex.
– Recurrence rates between 3% and 5%
– Fecal incontinence rates 5.6–25.2%
• Non-cutting or draining setons.
– Bridge for denitive treatment in an effort
to promote brosis decreases the inammatory response and aids in identifying the
internal opening at the time of the secondary procedure.
– Can be left in place to prevent recurrent
abscess formation in patients with Crohn’s
disease or in patients who are not deemed
candidates for additional surgery.
Advancement Flap
• Endorectal advancement ap (ERAF) has
been advocated as an effective treatment for
high transsphincteric or suprasphincteric
stulas.
Essential operative elements include:
– Debridement or excision of the stula tract
– Mobilization of a vascularized, tension-
free mucosal ap
– Coverage of the internal opening with
absorbable suture
7. The stulous tract is alternatively curetted or
cored out, and the defect in the internal anal
sphincter is closed with absorbable sutures.
8. The ap is advanced and sutured over the top
of the internal opening with absorbable
sutures (Fig.14.18c).
9. Vascular supply of the ap is maintained
through the submucosal plexus.
a
b
Technique
1. With the patient in prone jackknife position or
in lithotomy position, the internal opening of
the stula is exposed – this can be accomplished by everting the anal canal with the
Lone Star® retractor system (Fig.14.18a).
2. The internal opening is identied and the
crypt-bearing tissue excised.
3. A small rim of the anoderm, below the internal opening, is excised to create a neo-dentate
line.
4. The defect in the internal anal sphincter is
closed with absorbable sutures (2-0 Vicryl,
Ethicon Inc., Somerville, NJ) (Fig.14.18b).
5. A curvilinear incision is made at the level of
the internal opening extending laterally to create a wide tissue ap.
6. Dissection is performed in the submucosal
plane consisting of mucosa, submucosa, and
few supercial bers of the internal anal
sphincter and then mobilized over a distance
of 4–6cm proximally.
c
Fig. 14.18 (a) Lone Star to evert the anal canal. (b)
Closing the internal opening. (c) Securing the ap

196
B. R. Davis and K. R. Kasten
• The reported healing rates after ap repair
vary between 60% and 100%.
• Patient, disease, and technical factors appear
to be associated with either improved or worse
outcomes following ERAF repair of complex
anal stula.
– No difference in outcome seen:
◦ Fistula tract “core out” found no differ-
ence in recurrence.
◦ The location of the internal opening
(posterior vs. anterior) has no impact on
outcomes.
◦ Preoperative seton placement did not
impact outcomes of ap repairs.
◦ Medically induced bowel connement
has not been shown to improve
outcomes.
– Difference in outcome seen:
◦ Repeat anorectal advancement ap after
recurrence has been shown to be feasible but has been shown to be a risk factor for failure; success of ap
advancement was inversely correlated
with the number of prior attempts (0–1;
87% vs. 2 or more; 50%).
◦ The combination of brin glue with
advancement ap repair has also been
associated with worse outcomes when
compared to just ap repairs alone.
◦ Full-thickness aps have been shown to
be superior to partial thickness aps in
several studies (recurrence was 35% and
5%, respectively).
◦ Patient smoking, which both decreases
the mucosal blood ow, negatively
impacts success of ap repairs.
◦ Obesity negatively impacted advance-
ment ap repairs.
◦ Crohn’s disease has also been shown to
be a risk factor for failure.
• Reports have demonstrated some degree of
fecal incontinence following surgery, with
reductions in maximum resting and squeeze
pressures.
Ligation ofIntersphincteric Fistula
• Appropriate for all patients with high transsphincteric stulas assuming that a well-
formed stula track has been established
(Table14.4)
Technique
1. Identify the internal opening by injecting
peroxide or saline through the external
opening.
2. Incise circumanally in the intersphincteric
plane at the site of stula using a 3–4-cm
curvilinear incision.
3. Identify the intersphincteric tract using a soft
catheter or Lockhart–Mummery and lacrimal probes.
4. Dissect around the intersphincteric portion
of the stula tract being careful not to injure
or disrupt the tract. A right-angle probe can
be used for this purpose. Using narrow malleable retractors can facilitate exposure of
the intersphincteric plane. A Lone Star
retractor can also facilitate this exposure.
5. Hook the intersphincteric tract using a small
right-angle clamp.
6. Doubly ligate the tract close to the internal
and external sphincter with 2-0 Vicryl
(Ethicon Inc., Somerville, NJ), and transect
it between the sutures. Some surgeons prefer
a transxation suture.
7. Inject the external opening to conrm that
the tract was divided completely.
8. Curette the external portion of the stula
tract.
9. Drain the external opening.
10. Re-approximate the intersphincteric incision
wound loosely with an interrupted 3-0 Vicryl
(Ethicon Inc., Somerville, NJ).
• Variations in this technique include:
– Orienting the incision in a radial fashion
and performing a partial stulotomy up to
the external sphincter.
– Unroong the stula from the internal
opening to intersphincteric groove, ligating
the stula tract, but preserving the external
sphincter.
– Inserting a biologic mesh in the inter-
sphincteric groove or as a plug in the external tract.

14 Anorectal Abscess andFistula
Table 14.4 Experience with LIFT procedure
Author Year # patients Procedure
Rojanasakul etal. 2007 18 LIFT 4 94 Prospective
Shanwani etal. 2010 45 LIFT 7 82 Prospective
Ellis etal. 2010 31 bioLIFT 6 94 Retrospective
Bleier etal. 2010 39 LIFT 10 57 Retrospective
Ooi etal. 2011 25 LIFT 6 96 Prospective
Tan etal. 2011 93 LIFT 4 92 Retrospective review
Steiner etal. 18 LIFT 6 83 Retrospective
Aboulian etal. 2011 25 LIFT 24 68 Retrospective review
Mushaya etal. 2012 25 LIFT 4 68 Prospective
Abcarian etal. 2012 50 LIFT 15 74 Retrospective
Lo etal. 2012 25 LIFT 2 98 Retrospective
Van Onkelen etal. 2012 42 LIFT 12 51 Prospective
Chen etal. 2012 10 LIFT 6 100 Retrospective
Lehmann etal. 2013 17 LIFT 4 47 Prospective
Liu etal. 2013 38 LIFT 26 61 Retrospective
Madbouly etal. 2014 35 LIFT 56 74 Prospective
Ye, F etal. 2015 43 mLIFT 60 87 Retrospective
Bastawrous, A.
etal.
2015 66 mLIFT 21 71 Retrospective
Follow-up
(weeks) Percent healed (%) Type of study
observational
observational
observational
randomized
randomized
197
• There is not enough evidence that variants in
the surgical technique achieve better outcomes
(Bio-LIFT, LIFT-Plug, LIFT-Plus).
• Results
– Single-site studies show 74–79% success
at 3months.
– Hospitals that performed more LIFT pro-
cedures had higher rates of healing.
– Meta-analysis looking at the success of the
LIFT procedure 18 studies was reviewed
including 592 patients (65% male).
◦ The mean healing rate reported was
74.6%.
◦ The risk factors for failure were obesity,
smoking, multiple previous surgeries,
and the length of the stula tract.
◦ The median length of stula tract was
shorter in the healed group compared
with the failed group (4 cm vs. 6 cm,
P=0.004).
◦ The mean healing time was 5.5weeks.
◦ The patient satisfaction rates ranged
from 72% to 100%.
◦ No de novo incontinence developed sec-
ondary to the LIFT procedure.
• When the LIFT procedure fails, simple stulas can be managed with stulotomy or local
wound care.
Fibrin Glue
• The advantages of brin glue are its simple
and repeatable with no signicant learning
curve and no division of the sphincter
muscle.
• The glue is infused into the stulous tract with
the idea that collagen formation within the
tract will stimulate healing.
• It also stimulates the migration and proliferation of broblasts and pluripotent endothelial
cells to heal the stula.
• Between 7 and 14days postoperatively, plasmin that is present in the surrounding tissue

198
B. R. Davis and K. R. Kasten
lyses the brin clot as the tract is replaced by
synthesized collagen.
Technique
1. The patient is placed in the prone jackknife
position, and anesthesia is introduced (spinal,
general, or locoregional).
2. Both openings of the stula track are identied and mechanically curetted and irrigated
with normal saline or hydrogen peroxide.
3. If extensive side branching or undrained
abscess is encountered, the procedure is
aborted and a seton is placed.
4. A double-barreled syringe, containing the two
components of the glue, is inserted into the
external opening until the tip is seen at the
internal opening (Fig.14.19).
5. At this point the internal opening can be variably sutured closed or left opening depending
on the surgeon’s preference– there is no signicant advantage of one technique over the
other.
6. The syringe is depressed, which mixes the two
components as they are injected into the canal
while withdrawing the syringe. The tract is
lled completely until a bead of glue is seen at
the external opening.
7. The glue is allowed to set for 30–60s to form
its stable clot.
• The efcacy of brin glue injection as a curative procedure remains in question.
• Success rates vary greatly depending on the
etiology and complexity of the stulas, type of
brin glue used, and the length of patient follow-up. (Table14.5).
• Cintron etal. have reported the largest series
of patients with perianal stulas treated with
brin glue.
– Non-randomized prospective study.
– Three different types of brin glue: autolo-
gous, Viguard-FS (V.I. Technologies, Inc.,
NewYork, NY), and Tisseel VB (Baxter,
Deereld, IL).
Fig. 14.19 Fibrin glue injection into an anal stula
Table 14.5 Experience with brin glue
Author Year # patients Success rate (%) Follow-up (months)
Cintron etal. 1999 26 81 3.5
Cintron etal. 2000 79 61 18
Patrlj etal. 2000 69 74 28
Park etal. 2000 29 68 6
Sentovich 2001 20 85 10
Lindsey etal. 2002 42 63 4
Sentovich 2003 48 69 22
Loungnarath etal. 2004 39 31 26
Zmora etal. 2005 60 53 6
Gisbertz etal. 2005 27 33 7
Singer etal. 2005 75 21a 27
Maralcan etal. 2006 36 83 12
Ellis and Clark 2006 28 54 22
Dietz 2006 39 31 23
Witte etal. 2007 34 55 7
Adams etal. 2008 36 61 3
de Parades etal. 2010 30 50 12

14 Anorectal Abscess andFistula
199
– The majority of stulas were transsphinc-
teric, and 8% were secondary to Crohn’s
disease. The overall success rate was 66%,
with a mean follow-up of 1year.
– Healing rates correlated with stula com-
plexity: intersphincteric 82%, transsphincteric 62%, and Crohn’s-related 33%.
– The type of glue used did not affect success
rates.
– The average time to stula recurrence was
3.3 months while the latest was seen at
11months.
• Meta-analysis of 12 published studies of 378
patients with complex anal stula overall
healing rate was 53% with a wide variation
between studies (10–78%).
• The only factor that was found to account for
this diversity was stula complexity, with
series including a high proportion of complex
stulas reporting worse outcomes.
• No impact on continence.
• The heterogeneity of published data regarding
the success of this treatment makes it difcult
to recommend as a rst-line therapy of complex anal stula.
Anal Fistula Plug
• Surgisis® (Cook Surgical, Inc., Bloomington,
IN), a bioabsorbable xenograft, made of
lyophilized porcine intestinal submucosa, acts
as a tissue scaffold for host broblasts to promote healing and ingrowth of tissue into the
stula track (Fig.14.20).
Fig. 14.20 Bio A absorbable stula plug (W.L.GORE &
Associates, Newark, DE, Courtesy of Michael Stamos,
MD, with permission)
Technique
1. The patient is placed in the prone jackknife
position, and anesthesia is introduced (spinal,
general, or locoregional).
2. Both openings of the stula track are identied and irrigated with normal saline or hydrogen peroxide.
3. The plug is rehydrated, usually in a 0.9% normal
saline solution for 3–5min, before insertion.
4. The tapered end of the stula plug is then tied
to the anal side of the seton or silk suture and
pulled into the stula tract through the primary opening until it tted snugly.
5. The plug is then trimmed ush with the primary opening. A 2-0 Vicryl (Ethicon Inc.,
Somerville, NJ) suture is used to anchor the
plug to the mucosa/submucosa and internal
sphincter at the primary opening with a gureof-eight stitch, completely covering it with
mucosa at the completion of the stitch.
6. The excess plug protruding from the external
opening is trimmed such that the external
opening is partially open to allow drainage
and prevent infection.
• Since introduction of the AFP, success rates
have varied widely between 14% and 87%
(Table14.6).
– The plug extrusion rate was 8.7%.
– The proportion of non-Crohn’s patients
achieving stula closure varies widely
between studies, ranging from 0.2 to 0.
– The proportion of patients achieving stula
closure in patients with non-Crohn’s stula-in-ano is 0.54.
– Factors ascribed to the failures include:
◦ The absence of preoperative seton
placement
◦ Overly aggressive curetting of the s-
tula track resulting in widening of the
track
◦ Inadequate xation of the plug into the
internal opening
◦ Presence of multiple tracks
◦ Increased tract length, because stulas
longer than 4 cm were nearly 3 times
more likely to heal compared with
shorter stulas

200
Table 14.6 Experience with anal stula plug
Author Year Type of study # patients Success rate (%) Follow-up (months)
Johnson etal. 2006 Prospective 25 87 3
Champagne etal. 2006 Prospective 46 83 12
O’Connor etal. 2006 Prospective 20 80 10
Ellis 2007 Retrospective 13 92 6
Ky etal. 2008 Prospective 45 55 6.5
Christoforidis etal. 2008 Retrospective 47 43 6.5
Safar etal. 2009 Retrospective 36 14 4.2
Ortiz etal. 2009 Prospective randomized 15 20 12
El-Gazzaz etal. 2010 Retrospective 33 25 7.4
van Koperen etal. 2011 Prospective 31 29 11
Chan etal. 2012 Prospective 44 50 10.5
Cintron etal. 2013 Prospective 73 42 15
Tan etal. 2013 Retrospective 26 13 15
Adamina etal. 2014 Prospective 46 43.5 68
B. R. Davis and K. R. Kasten
– In a multicenter randomized controlled
Novel Techniques
trial, Garcia-Olmo et al. used ADSC to
treat complex cryptoglandular, rectovagi-
• Laser probe [Fistula laser closure (FiLaC™),
Biolitec, Germany], which destroys the stula
epithelium and simultaneously obliterates the
remaining stula tract.
– Includes closure of the internal opening by
means of an anorectal ap.
– Pilot study, 11 patients with cryptoglandu-
lar stula, underwent FiLaC™ procedure
with an overall success of 81%.
• Adipose-derived stem cells (ADSC) to treat
complex anal stula mostly in patients with
Crohn’s disease.
– Autologous ADSC obtained with liposuc-
tion with minimal adverse effects on the
patient.
nal, and Crohn’s-related stulas.
– Initially they achieved a 71% success rate
with ADSC, compared with 16% in the
control group (brin glue only).
– At 1year this had decreased to 62.5 and to
33% at 3years.
• Injectable form of Permacol (Tissue Science
Laboratories, Covington, GA), a type of porcine acellular collagen matrix, was modied
by centrifugation to form a paste and has been
used to inject anal stula in combination with
an ERAF.
– Studies are limited, but success rates in
non-Crohn’s patients have been reported as
high as 82%.(167)

Complex Anorectal Fistulas
GiulioA.Santoro andMaherA.Abbas
15
Key Concepts
• The history and physical examination are the
mandatory rst step, providing in most cases
the appropriate information to classify a stula as “simple” or “complex.” Anal continence should be evaluated using a validated
incontinence score such as the Cleveland
Clinic Florida Fecal Incontinence Score
(CCF-FIS) grading system.
• Imaging procedures include (in order of
authors’ preference) two- and three-dimensional endoanal ultrasound (2D/3D EAUS),
pelvic magnetic resonance imaging (MRI),
computed tomography (CT), and stulography. Imaging can provide invaluable information on the anatomy of the stula, including
the primary track, internal opening, horseshoe
extension, secondary cavities or extensions,
Electronic Supplementary Material The online
version of this chapter (https://doi.org/10.1007/978-3-
030-01165-9_15) contains supplementary material,
which is available to authorized users.
G. A. Santoro
Treviso Regional Hospital Italy, Treviso, Italy
M. A. Abbas (*)
Al Azhra Hospital Dubai, Dubai, UAE
e-mail: abbasm@clevelandclinicabudhabi.ae
and associated sphincter lesions, and is a useful guide in surgical management.
• Complex anal stula is challenging to treat
due to the risk of postoperative anal incontinence and the high rate of recurrence. Three
factors determine the outcome of surgical
treatment: patient-related factors, stula characteristics, and the surgeon choice of operation inclusive of its technical conduct.
• Each surgical procedure has advantages and
disadvantages, and the choice of operative
intervention should be individualized based
on patient-related factors and stula characteristics taking into account success rate as
well as impact on patient anal continence.
• Rectourethral stula is often the result of prostate cancer treatment whether surgical or radiotherapy-based. A multidisciplinary approach
involving a urologist and a colorectal surgeon is
essential. Small distal stulas and those not
radiation-induced can be amenable to a local
anal repair such as an endorectal advancement
ap. Large stulas, those induced by radiation,
or persistent/recurrent stulas are best
approached by a transperineal approach with a
gracilis interposition ap or in select cases by a
transabdominal approach with rectal excision.
Due to its rarity, rectourethral stula is best
managed in tertiary or quaternary centers with
experience managing this condition.
• Ileal-pouch stula is uncommon and can be
extremely challenging to manage due to the
© ASCRS (American Society of Colon and Rectal Surgeons) 2019
S. R. Steele et al. (eds.), The ASCRS Manual of Colon and Rectal Surgery,
https://doi.org/10.1007/978-3-030-01165-9_15
201
Соседние файлы в папке Библиотека им академика М.И. Перельмана
